How long does it take to stop taking Besudil? How long do I need to continue using it during treatment?

Belumosudil is a Rho-associated protein kinase 2 (ROCK2) inhibitor, mainly used to treat chronic graft-versus-host disease (cGVHD), especially in patients who are ineffective or resistant to multiple previous therapies (such as glucocorticoids). The drug improves cGVHD symptoms and helps patients alleviate disease progression by regulating inflammatory signals and immune cell activity.

The recommended dose of Besudil is 200 mg once a day. The specific dose is determined by the doctor based on the patient's condition. Treatment is usually long-term, and patients need to decide whether they can stop taking it based on their doctor's evaluation. At present, there is no fixed termination standard for the treatment time of besudil. It is generally recommended to continue taking it until the disease is significantly relieved or intolerable side effects occur.

During treatment, doctors will regularly evaluate the patient's condition and drug tolerance. If cGVHD symptoms persist, your doctor may gradually reduce the dose or even consider discontinuing the drug; however, if the disease remains active or relapses, you usually need to continue taking it. At the same time, patients should pay close attention to possible adverse reactions, such as abnormal liver function, high blood pressure, nausea, fatigue, etc., and adjust the medication regimen under the guidance of a doctor.
Patients are not allowed to stop taking Besudil on their own to avoid rebound of cGVHD symptoms or worsening of the condition. If there is a need to discontinue the drug or adjust the dose, it should be done under the guidance of a doctor and combined with other immunosuppressive treatments or supportive therapies to ensure the stability and long-term efficacy of the treatment.
Reference: https://www.rezuomib.com/